Menu
OPINION All
Losing weight shouldn't mean losing choice Partner content
Health
Health
Health
From invention to application: transforming the best UK science into better treatments for patients Partner content
Health
Researchers Shed New Light on the Benefits of UV Exposure Partner content
Health
Press releases

WATCH: How can we ensure patients access innovative medicines quickly?

WATCH: How can we ensure patients access innovative medicines quickly?

Credit: Unsplash

AbbVie

1 min read Partner content

What can the UK Government and others do to ensure the system keeps pace with scientific developments, helping patients overcome delays in accessing innovative new medicines?

Over recent decades, programmes such as the Early Access to Medicines Scheme and Accelerated Access Collaborative alongside the Cancer Drug Fund have pushed forward initiatives to improve access to medicines.

However, these changes have been introduced gradually and there has been a disconnect in how they interact resulting in a regulatory and access environment for medicines which is complex and confusing, often resulting in delays for patients in accessing new innovations.

Dods and Abbvie gathered a panel of experts – including Innovation Minister Lord Bethall – to discuss how government and industry can work together to ensure the best health technologies get into the hands of the patients who need them.

Speakers

  • Lord Bethell, Minister for Innovation
  • Chris Green MP, Chair of the Medical Research APPG and contributor to the Bridging the Gap report (Chair)
  • Zack Pemberton-Whiteley, Chair, Blood Cancer Alliance
  • Dominic Pivonka, Director of Market Access, AbbVie

Prepared January 2021

2020-GB-MNP-00103

Categories

Coronavirus Health